Controversy surrounding the efficacy of Ursa functions as obstacles in activation of OTC drugs

Published: 2014-03-27 13:11:00

Updated: 2014-03-27 13:11:00

There raising questions that controversy surrounding the efficacy of Ursa functions as obstacles in activation of OTC drugs.

L pharmacist from Korean Pharmacists for Democratic Society gave an interview to MBC 8 o'clock news desk on last September 2013, saying that "People in some hospital clearly classify Ursa 25mg, 50mg towards the category of digestive medicine...." and controversy sparked ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.